Xiaomou Wei
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 2
- Co-authors
- Shengming Dai (5 shared papers)Dong Wei (2 shared papers)Xiangyang Zhou (2 shared papers)Zhen Wu (2 shared papers)Guisheng Li (1 shared paper)Haixin Huang (1 shared paper)Wei Liang (3 shared papers)Bing Li (1 shared paper)
- Journals
- Disease Markers (2 papers)Tumor Biology (1 paper)Molecular Biology Reports (1 paper)Oncotarget (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaomou Wei
14 papers receiving 879 citations
Xiaomou Wei's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 438
- Molecular Biology 719
- Immunology 165
- Immunology and Allergy 18
- Biomaterials 34
Countries citing papers authored by Xiaomou Wei
This map shows the geographic impact of Xiaomou Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomou Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomou Wei more than expected).
Fields of papers citing papers by Xiaomou Wei
This network shows the impact of papers produced by Xiaomou Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomou Wei. The network helps show where Xiaomou Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomou Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer Hit paper breakdown → | 2008 | 683 |
| 2 | 2015 | 49 | |
| 3 | 2017 | 34 | |
| 4 | 2018 | 20 | |
| 5 | 2014 | 20 | |
| 6 | 2009 | 16 | |
| 7 | 2020 | 14 | |
| 8 | 2016 | 14 | |
| 9 | 2018 | 14 | |
| 10 | 2016 | 8 | |
| 11 | 2014 | 6 | |
| 12 | 2021 | 5 | |
| 13 | LncRNA TGFB2-AS1 regulates lung adenocarcinoma progression via act as a sponge for miR-340-5p to target EDNRB expression. | 2020 | 5 |
| 14 | 2016 | 2 |
About Xiaomou Wei
Xiaomou Wei is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Biomedical Engineering, having authored 14 papers that have together received 890 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Immunotherapy and Immune Responses (2 papers), Circular RNAs in diseases (2 papers), Bone Tissue Engineering Materials (2 papers), Metal and Thin Film Mechanics (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (438 citations), Molecular Biology (719 citations), Immunology (165 citations), Immunology and Allergy (18 citations) and Biomaterials (34 citations). Xiaomou Wei has collaborated with scholars based in China and United States. Frequent co-authors include Shengming Dai, Dong Wei, Xiangyang Zhou, Zhen Wu, Guisheng Li, Haixin Huang, Wei Liang, Bing Li, Haobo Pan and Xuan Zhu. Their work appears in journals such as Disease Markers, Tumor Biology, Molecular Biology Reports, Oncotarget and Journal of Biomedical Materials Research Part B Applied Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.